The working group will meet approximately once every other week during the second half of the Spring 2015 semester (see dates below) from 4:00 to 7:00. The location will alternate between the MIT Sloan School of Management and the Harvard Business School.
| Session | Date | Topic | Location |
| 1 | March 11 | Introduction, Mission, and Tasks | MIT |
| 2 | April 2 | Incentives for Scientists: How to Organize Innovation? | HBS |
| 3 | April 16 | Legal Liability, Insurance, and IP Issues | MIT |
| 4 | May 1 | Business Model and Ecosystems | MIT |
| 5 | May 14 | Operating Models and Next Steps | MIT |
Final Deliverable
The main goal of the working group is to produce a viable business plan for bringing the LaRC to fruition that provides details on all key aspects, including:
|
|
|
For concreteness, we propose to focus on a clinic specializing in providing beyond standard-of-care cancer treatments. These treatments may include the use of off-label drugs and other therapeutics generally regarded as safe in select patients based on an understanding of the unique biology driving each individual’s tumor, the treatment’s mechanism of action, and available human or animal efficacy data. The clinic will be staffed by a multidisciplinary team of oncologists, other doctors, and biomedical cancer scientists who can bring their collective expertise to each case. In addition, experts from outside the clinic, including those with expertise in drug repurposing, will be engaged on a regular basis. In doing so, the clinic will open new choices for patient care and contribute to medical innovation as treatment data is mined and shared.